Palavra-chave: T-CELL LYMPHOMA

PROGNOSIS TREATMENT PATIENTS FAILING T-CELL LYMPHOMA PROJECT COHORT STUDY FIRST-LINE THERAPY T-CELL PROJECT ALISERTIB RANDOMIZED PHASE III STUDY EXTRANODAL NATURAL KILLER PROSPECTIVE COHORT TCELL BRAZIL PROJECT OUTCOME OF PHERIPHERAL T-CELL BRAZIL PROJECT PRIMARY REFRACTORY